Mustard Seed Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2M Buy
1,306
+1
+0.1% +$1.01K 0.72% 30
2025
Q4
$1.4M Sell
1,305
-999
-43% -$955K 0.88% 25
2025
Q3
$1.76M Buy
2,304
+3
+0.1% +$2.23K 1.13% 21
2025
Q2
$1.79M Buy
2,301
+2
+0.1% +$1.55K 1.29% 20
2025
Q1
$1.9M Buy
2,299
+2
+0.1% +$1.66K 1.53% 18
2024
Q4
$1.77M Buy
2,297
+2
+0.1% +$1.66K 1.44% 18
2024
Q3
$2.03M Buy
2,295
+1
+0% +$899 1.69% 18
2024
Q2
$2.08M Buy
2,294
+2
+0.1% +$1.6K 1.99% 14
2024
Q1
$1.78M Buy
2,292
+2
+0.1% +$1.42K 1.78% 18
2023
Q4
$1.33M Buy
+2,290
New +$1.34M 1.51% 17

Other funds holding LLY

Mustard Seed Financial's LLY Position: Q1 2026 in Review

Mustard Seed Financial increased its Eli Lilly (LLY) stake by 0.08% in Q1 2026, buying an estimated $1.01K and bringing the position to 1,306 shares worth $1.2M. The position accounts for 0.72% of the portfolio, ranked #30.

Mustard Seed Financial first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.08M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Mustard Seed Financial held 1,306 shares of Eli Lilly worth $1.2M as of Q1 2026.
  • Mustard Seed Financial bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.72% of Mustard Seed Financial's portfolio in Q1 2026, its #30 holding.
  • Mustard Seed Financial first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Mustard Seed Financial's Eli Lilly position peaked at $2.08M in Q2 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Mustard Seed Financial's 13F filing for Q1 2026, filed 27 Apr 2026.